Cargando…
FXR activation alleviates tacrolimus-induced post-transplant diabetes mellitus by regulating renal gluconeogenesis and glucose uptake
BACKGROUND: Tacrolimus (FK506)-induced diabetes mellitus is one of the most important factors of post-transplant diabetes mellitus (PTDM). However, the detailed mechanisms underlying PTDM are still unclear. Farnesoid X receptor (FXR) regulates glycolipid metabolism. The objective of this study was t...
Autores principales: | Li, Ling, Zhao, Huijia, Chen, Binyao, Fan, Zhipeng, Li, Ning, Yue, Jiang, Ye, Qifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909577/ https://www.ncbi.nlm.nih.gov/pubmed/31836014 http://dx.doi.org/10.1186/s12967-019-02170-5 |
Ejemplares similares
-
Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular Carcinoma
por: Li, Ling, et al.
Publicado: (2019) -
New-Onset Diabetes Mellitus in Post-renal Transplant Patients on Tacrolimus and Mycophenolate: A Systematic Review
por: Nandula, Savitri Aninditha, et al.
Publicado: (2022) -
Fast Tacrolimus Metabolism Does Not Promote Post-Transplant Diabetes Mellitus after Kidney Transplantation
por: Jehn, Ulrich, et al.
Publicado: (2022) -
H(+)-ATPase blockade reduced renal gluconeogenesis and plasma glucose in a diabetic rat model
por: Tojo, Akihiro, et al.
Publicado: (2018) -
Role of FXR in Renal Physiology and Kidney Diseases
por: Guo, Yanlin, et al.
Publicado: (2023)